Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study

To evaluate the safety and efficacy of SHR-3821 combined with fruquintinib in the advanced colorectal cancer after failure of standard therapy

Participants needed: 12
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Meng QiuUpdated: Apr 7, 2026
Eligibility criteria

Histologically or cytologically confirmed unresectable recurrent or metastatic c... [+11]

Presence of concurrent active malignancies other than the primary tumor (except... [+21]

Read more
Status: Not yet recruiting

First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study

This multicenter, randomized, controlled, phase III study is conducted to evaluate the efficacy and safety of first line mCapOX plus Cetuximab versus mFOLFOX6 plus Cetuximab for RAS/BRAF wild-type, MSS, Unresectable Left-Sided mCRC.

Participants needed: 452
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Meng QiuUpdated: Sep 27, 2024Locations: 1
Eligibility criteria

Able to provide written informed consent and can understand and comply with the... [+7]

Patients with mCRC who were initially resectable with R0 resection or radiofrequ... [+15]

Read more